Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-04-13 @ 8:27 AM
Study NCT ID:
NCT02536794
Status:
COMPLETED
Last Update Posted:
2022-05-17
First Post:
2015-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer
Sponsor:
Northwestern University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-22
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-28
First Submit QC Date:
None
Study First Post Date:
2015-09-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-26
Results First Submit QC Date:
None
Results First Post Date:
2021-04-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-22
Last Update Post Date:
2022-05-17
Last Update Post Date Type:
ACTUAL